ENvue Medical, Inc. (FEED) stock
FEEDOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$0.50+0.13 (+34.73%)
Close on Oct 19, 2026Market cap $3.08MP/E –Yield –
ENvue Medical revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
ENvue Medical's revenue for the twelve months ending Jun 30, 2026 was $1.93M, down 17.7% year over year. For fiscal 2025 it was $2.55M, down 0.2% from the year before. Over ten years it grew 33.0% a year on average. The highest annual figure on record is $2.56M in fiscal 2024.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.55M | -0.2% |
| FY2024 | Dec 31, 2024 | $2.56M | +12.0% |
| FY2023 | Dec 31, 2023 | $2.28M | +203.6% |
| FY2022 | Dec 31, 2022 | $752.00K | -55.6% |
| FY2021 | Dec 31, 2021 | $1.70M | +172.1% |
| FY2020 | Dec 31, 2020 | $623.00K | +17.5% |
| FY2019 | Dec 31, 2019 | $530.00K | +66.7% |
| FY2018 | Dec 31, 2018 | $318.00K | +33.1% |
| FY2017 | Dec 31, 2017 | $239.00K | +4.4% |
| FY2016 | Dec 31, 2016 | $229.00K | +55.8% |
| FY2015 | Dec 31, 2015 | $147.00K | -27.6% |
| FY2014 | Dec 31, 2014 | $203.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $239.00K | -51.6% |
| Q1 FY2026 | Mar 31, 2026 | $653.00K | -36.3% |
| Q4 FY2025 | Dec 31, 2025 | $312.00K | -29.7% |
| Q3 FY2025 | Sep 30, 2025 | $722.00K | +92.0% |
| Q2 FY2025 | Jun 30, 2025 | $494.00K | -39.5% |
| Q1 FY2025 | Mar 31, 2025 | $1.03M | +11.3% |
| Q4 FY2024 | Dec 31, 2024 | $444.00K | -62.3% |
| Q3 FY2024 | Sep 30, 2024 | $376.00K | -17.9% |
| Q2 FY2024 | Jun 30, 2024 | $817.00K | +177.9% |
| Q1 FY2024 | Mar 31, 2024 | $921.00K | +160.2% |
| Q4 FY2023 | Dec 31, 2023 | $1.18M | +1113.4% |
| Q3 FY2023 | Sep 30, 2023 | $458.00K | -5.6% |
| Q2 FY2023 | Jun 30, 2023 | $294.00K | +8.1% |
| Q1 FY2023 | Mar 31, 2023 | $354.00K | -54.3% |
| Q3 FY2022 | Sep 30, 2022 | $97.00K | -80.6% |
| Q2 FY2022 | Jun 30, 2022 | $485.00K | +52.5% |
| Q1 FY2022 | Mar 31, 2022 | $272.00K | +164.1% |
| Q4 FY2021 | Dec 31, 2021 | $775.00K | +761.1% |
| Q3 FY2021 | Sep 30, 2021 | $499.00K | +232.7% |
| Q2 FY2021 | Jun 30, 2021 | $318.00K | +18.2% |
| Q1 FY2021 | Mar 31, 2021 | $103.00K | -9.6% |
| Q4 FY2020 | Dec 31, 2020 | $90.00K | +3.4% |
| Q3 FY2020 | Sep 30, 2020 | $150.00K | +48.5% |
| Q2 FY2020 | Jun 30, 2020 | $269.00K | +2.3% |
| Q1 FY2020 | Mar 31, 2020 | $114.00K | +44.3% |
| Q4 FY2019 | Dec 31, 2019 | $87.00K | +61.1% |
| Q3 FY2019 | Sep 30, 2019 | $101.00K | +87.0% |
| Q2 FY2019 | Jun 30, 2019 | $263.00K | +99.2% |
| Q1 FY2019 | Mar 31, 2019 | $79.00K | +2.6% |
| Q4 FY2018 | Dec 31, 2018 | $54.00K | -22.9% |
| Q3 FY2018 | Sep 30, 2018 | $54.00K | -16.9% |
| Q2 FY2018 | Jun 30, 2018 | $132.00K | +153.8% |
| Q1 FY2018 | Mar 31, 2018 | $77.00K | +48.1% |
| Q4 FY2017 | Dec 31, 2017 | $70.00K | +12.9% |
| Q3 FY2017 | Sep 30, 2017 | $65.00K | – |
| Q2 FY2017 | Jun 30, 2017 | $52.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $52.00K | – |
| Q2 FY2016 | Jun 30, 2016 | $62.00K | – |
See a number that looks wrong?